Ginkgo Bioworks Holdings (DNA) Cash from Investing Activities Growth (1y) (2021 - 2026)
Powered by 
Analysis
Ginkgo Bioworks Holdings (DNA) Cash from Investing Activities Growth (1y) (2021 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 42.38 Bn | 40.30 Bn | 1.44 Bn | -10.12% |
| 2 | Medpace Holdings | 16.51 Bn | 16.01 Bn | 201.64 Mn | -296.76% |
| 3 | Charles River Laboratories International | 13.16 Bn | 12.97 Bn | 452.07 Mn | 175.25% |
| 4 | Icon | 12.39 Bn | 11.46 Bn | 479.29 Mn | -183.54% |
| 5 | Fortrea Holdings | 1.57 Bn | 1.40 Bn | 139.20 Mn | 6.67% |
| 6 | Evotec SE | 621.88 Mn | 196.00 Mn | - | - |
| 7 | Ginkgo Bioworks Holdings | 419.14 Mn | 334.60 Mn | 18.44 Mn | 117.35% |
| 8 | Champions Oncology | 71.79 Mn | 71.79 Mn | 7.03 Mn | 5.93% |
| 9 | MindWalk Holdings | 59.83 Mn | 51.55 Mn | 1.82 Mn | 10,728.48% |
| 10 | VivoSim Labs | 1.45 Mn | 1.45 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 117.35% |
| Mar 31, 2026 | 111.64% |
| Dec 31, 2025 | 826.78% |
| Sep 30, 2025 | -613.88% |
| Jun 30, 2025 | -138.02% |
| Mar 31, 2025 | -1,540.66% |
| Dec 31, 2024 | 71.97% |
| Sep 30, 2024 | -201.69% |
| Jun 30, 2024 | -139.14% |
| Mar 31, 2024 | 37.62% |
| Dec 31, 2023 | -256.94% |
| Sep 30, 2023 | 92.73% |
| Jun 30, 2023 | 23.45% |
| Mar 31, 2023 | 46.05% |
| Dec 31, 2022 | 603.41% |
| Sep 30, 2022 | -52.37% |
| Jun 30, 2022 | 38.73% |
| Mar 31, 2022 | -56.14% |
| Dec 31, 2021 | 114.67% |